AAIC: Proving drugs modify Alzheimer’s disease faces skepticism

WASHINGTON – Proving disease modification of Alzheimer’s disease in a clinical drug trial may not be easy.

Some researchers developing drugs for treating Alzheimer’s disease hope to find a way to...